We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.


Phase III

Enhancing the patient experience

When the drug product is being tested in larger groups of patients and nearing registration, it is important to begin integrating tools that further improve the patient's therapeutic experience and drive medication adherence.

West has collaborated with HealthPrize Technologies, Noble and Insight Product Development to develop a multi-sensory, end-to-end patient training and education program for the SmartDose® platform. The SmartDose platform allows patients to self-administer medication in accordance with their prescribed treatment and was developed with extensive human factors testing and analysis to understand the interaction between the patient and the delivery system.
West Analytical Services also provides standard and custom analysis for delivery system and device performance, functionality, device verification studies and package qualification.
Learn more about the West products and services that can be incorporated into the final labeling: Adherence Technologies Reconstitution and Transfer Systems
Contract Manufacturing
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringes
Analytical Services

  • Leachables Analysis
  • Extractables Analysis
  • Performance Testing/Design Verification Studies
  • Process Validation Testing
  • Functional Analysis
  • Container Closure Integrity Testing
  • Particle Analysis and Testing   







Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko Ltd.

SmartDose® is a registered trademark of Medimop Medical Projects, Ltd., a subsidiary of West Pharmaceutical Services, Inc.